The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© (c) Copyright Thomson Reuters 2018.Takeda CEO prescribes surgical R&D cuts after Shire deal
By Ben Hirschler LONDON©2024 GPlusMedia Inc.
2 Comments
Login to comment
englisc aspyrgend
Such deals usually have more to do with CEO hubris than good economic sense, and this one looks a case in point. They invariably destroy shareholder value (like the deal creating GSK did).